Oncoinvent ASA (ONCIN) — Strategic Asset Allocation Index

Latest as of June 2025: 0.1%

Oncoinvent ASA (ONCIN) has a Strategic Asset Allocation Index of 0.1% as of June 2025. Strategic assets (PP&E of Nkr75.00K plus long-term investments of Nkr-) total Nkr75.00K, measured against net assets of Nkr67.00 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base.

SAAI

0.1%
Strategic Assets / Net Assets

Strategic Assets

Nkr75.00K
PP&E + LT Investments

PP&E

Nkr75.00K
NOK

Net Assets

Nkr67.00 Million
NOK

Oncoinvent ASA Strategic Asset Allocation Index (2022–2025)

This chart shows how Oncoinvent ASA's Strategic Asset Allocation Index has evolved across 4 annual periods from 2022 to 2025. As of June 2025, the index stands at 0.1%, representing strategic assets of Nkr75.00K against net assets of Nkr67.00 Million NOK. Explore cash efficiency ratio of Oncoinvent ASA to assess how effectively this company generates cash.

Annual Strategic Asset Allocation Index for Oncoinvent ASA (2022–2025)

The table below presents the year-by-year Strategic Asset Allocation Index for Oncoinvent ASA from 2022 to 2025, covering 4 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For the full company profile including market capitalisation, see ONCIN stock market capitalisation.

Year SAAI Strategic Assets (NOK) PP&E LT Investments Net Assets Change (pp)
2025 10.6% Nkr15.58 Million Nkr15.58 Million Nkr- Nkr146.32 Million ▲ +9.5 pp
2024 1.2% Nkr1.25 Million Nkr1.25 Million Nkr- Nkr108.33 Million ▲ +0.8 pp
2023 0.3% Nkr431.00K Nkr431.00K Nkr- Nkr127.48 Million ▲ +0.3 pp
2022 0.0% Nkr43.00K Nkr43.00K Nkr- Nkr88.50 Million
pp = percentage points